Yong Bae Kim
Overview
Explore the profile of Yong Bae Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
307
Citations
2370
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Byun H, Kim H, Son J, Cho Y, Kwon Y, Kim D, et al.
Radiother Oncol
. 2025 Feb;
206:110785.
PMID: 39952437
Purpose: This prospective, randomized clinical trial evaluated the effects of bra-wearing during radiotherapy on breast-shape reproducibility, dosimetry, and treatment toxicities in patients with breast cancer. Methods: Thirty-eight patients with breast...
2.
Kim M, Yoon S, Park S, Park K, Chung J, Kim Y
World Neurosurg
. 2025 Feb;
196:123756.
PMID: 39921131
No abstract available.
3.
Han M, Choi S, Hong C, Kim Y, Koom W, Kim J, et al.
Radiat Oncol J
. 2025 Jan;
42(4):295-307.
PMID: 39748530
Purpose: This report offers a detailed examination of the inception and current state of the Heavy-ion Therapy Center (HITC) at the Yonsei Cancer Center (YCC), setting it apart as the...
4.
Lee J, Byun H, Kim Y, Shin J, Kim Y
Int J Radiat Oncol Biol Phys
. 2024 Dec;
PMID: 39732344
Purpose: This study aimed to evaluate the use of chatbot and video education to reduce anxiety in patients with breast cancer undergoing radiation therapy (RT). Methods And Materials: This randomized...
5.
Kim N, Kim S, Cho W, Park W, Chang J, Kim Y, et al.
Int J Radiat Oncol Biol Phys
. 2024 Dec;
PMID: 39672514
Purpose: Given the aggressive nature and poor prognosis of triple-negative breast cancer (TNBC), adjuvant capecitabine has been the standard therapy for residual disease after preoperative systemic therapy (PST). However, the...
6.
Chun S, Park S, Kim Y, Ahn S, Kim K, Shin K
Pract Radiat Oncol
. 2024 Dec;
PMID: 39667667
Purpose: The American Society for Radiation Oncology (ASTRO) has recently published new guidelines for the eligibility for partial breast irradiation (PBI). This study aims to evaluate the eligibility rates of...
7.
Kim M, Yoon S, Park S, Park K, Chung J, Kim Y
World Neurosurg
. 2024 Oct;
192:e533-e538.
PMID: 39414133
Background: Aneurysmal subarachnoid hemorrhage (aSAH) has an incidence of 6-7 per 100,000 person-years. Despite advancements in treatment, 26% of patients die and 19% remain dependent after hemorrhage. Long-term neuropsychological sequelae...
8.
Han H, Kim S, Kim J, Kim Y, Kim S, Chan You S, et al.
Sci Rep
. 2024 Oct;
14(1):24010.
PMID: 39402128
Preventive treatments for unruptured intracranial aneurysms (UIAs) are used worldwide. However, the long-term effects to cognition have been underestimated. Using representative sample data from the National Health Insurance Service-Senior Cohort...
9.
Byun H, Park H, Choi S, Park S, Chang J, Lee I, et al.
Pract Radiat Oncol
. 2024 Oct;
PMID: 39362597
Purpose: The optimal extent of regional nodal irradiation (RNI) in postoperative radiation therapy for breast cancer, particularly regarding axillary level 1 (AXL1), remains uncertain. This study aimed to compare clinical...
10.
Kim J, Byun S, Kim M, Shin K, Kim D, Lee H, et al.
J Pers Med
. 2024 Sep;
14(9).
PMID: 39338195
Background: We designed a multi-institutional retrospective study to investigate the previously unreported failure pattern, survivals, and prognostic factors after postoperative radiotherapy (PORT) in triple negative breast cancer (TNBC) patients in...